About this trial
A cross-sectional, observational study aims to evaluate the relationship between Helicobacter pylori infection and disease activity in patients diagnosed with systemic lupus erythematosus (SLE), using a combination of structured patient interviews, standardized disease assessments, and laboratory detection of H. pylori by stool antigen testing .
Eligibility criteria
Qualifiers
Adult patients (aged ≥18 years) with a confirmed diagnosis of SLE according to the American College of Rheumatology (ACR) or Systemic Lupus International Collaborating Clinics (SLICC) classification criteria.
Disqualifiers
Patients with a history of gastric surgery or known gastrointestinal malignancy.
Patients currently receiving immunosuppressive therapy for conditions other than SLE.
Patients with coexisting autoimmune diseases other than SLE.
Pregnant or lactating women.
Trial design
Treatments tested in this trial
- Not listed